Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong

Hong Kong Medical Journal

Volumn 11, Issue 6, 2005, Pages 438-444

  Tam, T K W ^a   Lau, C M ^a   Tsang, L C Y ^a   Ng, K K ^a   Ho, K S ^a   Lai, T C ^a  

^a Shaukiwan Jockey Club Clinic   (Hong Kong)

Author keywords

Diabetic retinopathy; Disease progression; Prevalence; Primary health care; Risk factors

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; DEMOGRAPHY; DIABETIC RETINOPATHY; DISEASE COURSE; EYE FUNDUS; FEMALE; HONG KONG; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT; PHOTOGRAPHY; PREVALENCE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 30944451540     PISSN: 10242708     EISSN: 10242708     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Janus ED, Watt NM, Lam KS, et al. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. Diabet Med 2000;17:741-5.
2. Chan JC, Yeung VT, Chow CC, et al. A manual for management of diabetes mellitus - Hong Kong Chinese perspective. Hong Kong: The Chinese University Press; 1998.
3. Sharma S, Oliver-Fernandez A, Liu W, Buchholz P, Walt J. The impact of diabetic retinopathy on health-related quality of life. Curr Opin Ophthalmol 2005;16:155-9.
4. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol 1976;81:383-96.
5. Photocoagulation for diabetic maculopathy. A randomized controlled clinical trial using the xenon arc. British Multicentre Study Group. Diabetes 1983;32:1010-6.
6. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981;88:583-600.
7. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(Suppl 5):766S-785S.
8. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98(5 Suppl):741S-756S.
9. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987;94:761-74.
10. A protocol for screening for diabetic retinopathy in Europe. Retinopathy Working Party. Diabet Med 1991;8:263-7.
11. Freudenstein U, Verne J. A national screening programme for diabetic retinopathy. Needs to learn the lessons of existing screening programmes. BMJ 2001;323:4-5.
12. Christie B. Scotland to start screening programme for diabetic retinopathy. BMJ 2002;324:871.
13. Javitt JC, Aiello LP, Chiang Y, Ferris FL 3rd, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994;17:909-17.
14. Javitt JC, Aiello L. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164-9.
15. Dasbach EJ, Fryback DG, Newcomb PA, Klein R, Klein BE. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991;29:20-39.
16. Higgs ER, Harney BA, Kelleher A, Reckless JP. Detection of diabetic retinopathy in the community using a non-mydriatic camera. Diabet Med 1991;8:551-5.
17. Pugh JA, Jacobson JM, Van Heuven WA, et al. Screening for diabetic retinopathy. The wide-angle retinal camera. Diabetes Care 1993;16:889-95.
18. Kohner EM. Diabetic retinopathy. BMJ 1993;307:1195-9.
19. Lau HC, Voo YO, Yeo KT, Ling SL, Jap A. Mass screening for diabetic retinopathy - a report on diabetic retinal screening in primary care clinics in Singapore. Singapore Med J 1995;36:510-3.
20. Siu SC, Ko TC, Wong KW, Chan WN. Effectiveness of non-mydriatic retinal photography and direct ophthalmoscopy in detecting diabetic retinopathy. Hong Kong Med J 1998;4:367-70.
21. Hutchinson A, McIntosh A, Peters J, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review. Diabet Med 2000;17:495-506.
22. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
23. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-63.
24. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima indians. Diabetes Care 2003;26:320-6.
25. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):786S-806S.
26. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9.
27. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (2nd part) [in French]. Diabetes Metab 1977;3:173-82.
28. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-54.
29. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65.
30. Fujisawa T, Ikegami H, Yamato E, et al. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus. Diabet Med 1999;16:522-6.
31. Mouton DP, Gill AJ. Prevalence of diabetic retinopathy and evaluation of risk factors. A review of 1,005 diabetic clinic patients. S Afr Med J 1988;74:399-402.
32. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
33. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ 1998;317:713-20.
34. Segato T, Midena E, Grigoletto F, et al. The epidemiology and prevalence of diabetic retinopathy in the Veneto region of north east Italy. Veneto Group for Diabetic Retinopathy. Diabet Med 1991;8 Spec No:S11-6.
35. Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361:195-200.